Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Malignant Eye Neoplasm — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Malignant Eye Neoplasm

Cancer Family

Malignant Eye Neoplasm

CI-CAN-00000231Explore in graph →

83 active trials2 approved drugs19 evidence items

NCIt: C4767

Overview
Statistics
Survival
Genomics7
Variants & evidence19
Drugs12
Trials446
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

446 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 83
Recruiting: 44
Ph III recruiting: 10
Growth YoY: —
Industry share: 30%
Top sponsor: IDEAYA Biosciences
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (67)

StatusAll Active (any)Completed 213 Recruiting 59 Terminated 56 Unknown 48 Active Not Recruiting 43 Withdrawn 16 Not Yet Recruiting 5 Enrolling By Invitation 4 No Longer Available 1 Available 1

PhaseAll Early Phase 1 6 N/A 43 Phase 1 149 Phase 2 177 Phase 3 29 Phase 4 5

No study matches these filters